PharmStars, the first and only pharma-focused accelerator for digital health startups, was founded just weeks ago and already has Boehringer Ingelheim, Eli Lilly and Takeda join their platform. PharmStars’ focus is to connect drugmakers to digital health startups.

Founder and CEO Naomi Fried decided to launch the company after noticing a disconnect between pharma companies searching for digital health solutions and the entrepreneurial tech startups that were coming up with new ideas.

"Our mission is to facilitate and accelerate successful partnerships between digital health startups and pharma, leading to greater success for each and faster adoption of digital health to improve patient outcomes." - Naomi Fried PhD, Founder & CEO, PharmStars

Click here to read the entire article.